Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-31

Clinical Trial Update: Inhaled Tobramycin in BPD [Phase 1]

View source ↗

Summary

A Phase 1 trial testing inhaled tobramycin in infants with bronchopulmonary dysplasia has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBI (tobramycin) inhalation solution (tobramycin)

Snippet

Sponsor: Erik Allen Jensen | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: COMPLETED | Results posted: 2025-01-31